Dale H. Scott

Mr. Scott has more than 25 years of experience in the health-care related field, including more than 10 years experience in the biotechnology industry.
As a former Vice President, Development at Immunex Corporation, he directed Enbrel development from Phase 2 through its approval in rheumatoid arthritis.
He also served as Enbrel Business Operations Director the first year Enbrel was on the market.
His experience includes negotiation and oversight of contract manufacturers and development partner agreements, directing the project management group, and managing pipeline molecules in their transition from research to development.